Related Experiment Video
Updated: Jan 7, 2026

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
Published on: June 13, 2025
Representation meets optimization: Training PINNs and PIKANs for gray-box discovery in systems pharmacology
Nazanin Ahmadi Daryakenari1, Khemraj Shukla2, George Em Karniadakis2
1Center for Biomedical Engineering, Brown University, Providence, RI 02912, USA.
None:
Physics-Informed Kolmogorov-Arnold Networks (PIKANs) have been gaining attention as an effective counterpart to the original multilayer perceptron-based Physics-Informed Neural Networks (PINNs). Both representation models can address inverse problems and facilitate gray-box system identification. However, a comprehensive understanding of their performance in terms of accuracy and speed remains underexplored. In particular, we introduce a modified PIKAN architecture, tanh-cPIKAN, which is based on Chebyshev polynomials for parametrization of the univariate functions with an extra nonlinearity for enhanced performance. We then present a systematic investigation of how the choices of optimizer, representation, and training configuration influence the performance of PINNs and PIKANs in the context of systems pharmacology modeling. We benchmark a wide range of optimizers using simple but representative pharmacokinetic and pharmacodynamic models. We use the new Optax library [1] as well as a new class of self-scaled optimizers developed in Optimistix library [2] to identify the most effective combinations for learning gray-boxes under ill-posed, non-unique, and data-sparse conditions. We examine the influence of model architecture (MLP vs. KAN), numerical precision (single vs. double), the need for warm-up phases for second-order methods, and sensitivity to the initial learning rate. We also assess the optimizer scalability for larger models and analyze the trade-offs introduced by JAX in terms of computational efficiency and numerical accuracy. Using two representative systems pharmacology examples, a pharmacokinetics model and a chemotherapy drug response model, we offer practical guidance on selecting optimizers and representation models/architectures for robust and efficient gray-box discovery. Our findings provide actionable insights for improving the training of physics-informed networks in systems pharmacology, systems biology, and beyond.
More Related Videos
10:44Inherent Dynamics Visualizer, an Interactive Application for Evaluating and Visualizing Outputs from a Gene Regulatory Network Inference Pipeline
Published on: December 7, 2021
07:35A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
Published on: October 13, 2023
Related Concept Videos
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Model Approaches for Pharmacokinetic Data: Physiological Models
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Mechanistic Models: Overview of Compartment Models
Analysis of Population Pharmacokinetic Data